Chloroquine and hydroxychloroquine in the treatment of COVID-19: the never-ending story
ABSTRACT: The anti-malarial drugs chloroquine (CQ) and hydroxychloroquine (HCQ) have been suggested as promising agents against the new coronavirus SARS-CoV-2 that induces COVID-19 and as a possible therapy for shortening the duration of the viral disease. The antiviral effects of CQ and HCQ have be...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7847229/ https://www.ncbi.nlm.nih.gov/pubmed/33515285 http://dx.doi.org/10.1007/s00253-021-11094-4 |